Summary & Overview
HCPCS J0706: Injection, Caffeine Citrate, 5 mg
HCPCS Level II code J0706 denotes an injection of caffeine citrate, 5 mg, an injectable pharmacologic agent commonly used in acute care—particularly neonatal care—for management of apnea and related indications. Nationally, this code is relevant for hospital billing, inpatient neonatal services, and emergency medication administration where parenteral caffeine is used. Payers apply varying coverage, payment policies, and prior authorization criteria for injectable medications, making clear coding essential for accurate claims processing and clinical documentation.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and the types of benchmarks and policy considerations that affect payment and utilization for J0706. The publication outlines common billing practice implications, expected service lines, and areas where payers often set specific criteria or require supporting documentation. This summary is designed to help coding and billing professionals, revenue cycle staff, and health policy analysts understand the scope and administrative considerations tied to HCPCS Level II code J0706 at a national level.
Data not available in the input is identified where applicable.
Billing Code Overview
HCPCS Level II code J0706 describes an injection of caffeine citrate, 5 mg. The service represents administration of a specified dose of caffeine citrate, typically used in acute care and neonatal settings for management of apnea of prematurity and related conditions.
Service type: Medication administration / injectable pharmacologic agent
Typical site of service: Hospital inpatient, neonatal intensive care unit (NICU), emergency department, or other acute care settings where parenteral medications are administered.
Clinical & Coding Specifications
Clinical Context
A premature neonate in a neonatal intensive care unit (NICU) with apnea of prematurity receives an intravenous or oral dose of caffeine citrate to stimulate respiratory drive. Typical workflow: NICU team orders J0706 (injection, caffeine citrate, 5 mg) or an equivalent oral/iv formulation; pharmacy compounds and dispenses the appropriate weight-based dose; nurse documents indication, route, dose, lot numbers, and administration time; monitoring includes cardiorespiratory observation and periodic blood pressure and heart rate checks. Billing uses J0706 for each 5 mg unit administered; common settings are inpatient NICU, neonatal step-down, or newborn nursery for preterm infants with recurrent apnea or bradycardia episodes requiring methylxanthine therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Place of Service not applicable (per payer) | Rarely used; follow payer guidance when no other modifier applies |
22 | Increased procedural services |